✉news HealthPandemics first seen 2 d ago, last 1 d ago, peak #6
Gottlieb Discusses FDA Rare Disease Framework and Measles Outbreak
Original: Dr. Scott Gottlieb on FDA's Rare Disease Framework, measles outbreak latest and rise of peptides
Dr. Scott Gottlieb, former commissioner of the US Food and Drug Administration, spoke publicly about the agency's rare disease framework, the latest developments in the ongoing measles outbreak, and the growing use of peptide-based therapies. The interview ties together current public health concerns over measles with regulatory policy questions at the FDA and rising interest in peptides as a class of treatments.
Why now: A former FDA commissioner commenting on the measles outbreak and agency policy draws attention amid ongoing public health concerns.
Rank over time, top of the chart is #1. 10 snapshots from 2 d ago to 1 d ago.
Evidence
- Dr. Scott Gottlieb on FDA's Rare Disease Framework, measles outbreak latest and rise of peptides · CNBC
API: https://socialmediatrends-api.osmike.com/v1/trends/2867340